Liangliang Zhao1, Chenguang Wang1, Delu Song2, Yafeng Li2, Ying Song2, Guanfang Su3, Joshua L Dunaief2. 1. Department of Ophthalmology, The Second Hospital of Jilin University, Jilin, China F. M. Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, University of Pennsylvania, Philadelphia, Pennsylvania, United States. 2. F. M. Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, University of Pennsylvania, Philadelphia, Pennsylvania, United States. 3. Department of Ophthalmology, The Second Hospital of Jilin University, Jilin, China.
Abstract
PURPOSE: Oxidative stress and inflammation have key roles in the light damage (LD) model of retinal degeneration as well as in age-related macular degeneration (AMD). We sought to determine if lipoic acid (LA), an antioxidant and iron chelator, protects the retina against LD. METHODS: Balb/c mice were treated with LA or control saline via intraperitoneal injection, and then were placed in constant cool white light-emitting diode (LED) light (10,000 lux) for 4 hours. Retinas were evaluated at several time points after LD. Photoreceptor apoptosis was assessed using the TUNEL assay. Retinal function was analyzed via electroretinography (ERG). Retinal degeneration was assessed after LD by optical coherence tomography (OCT), TUNEL analysis, and histology. The mRNAs of several oxidative stress, inflammation, and iron-related genes were quantified by quantitative PCR (qPCR). RESULTS: The LD resulted in substantial photoreceptor-specific cell death. Dosing with LA protected photoreceptors, decreasing the numbers of TUNEL-positive photoreceptors and increasing the number of surviving photoreceptors. The retinal mRNA levels of genes indicating oxidative stress, inflammation, and iron accumulation were lower following LD in mice treated with LA than in control mice. The ERG analysis demonstrated functional protection by LA. CONCLUSIONS: Systemic LA is protective against light-induced retinal degeneration. Since this agent already has proven protective in other retinal degeneration models, and is safe and protective against diabetic neuropathy in patients, it is worthy of consideration for a human clinical trial against retinal degeneration or AMD. Copyright 2014 The Association for Research in Vision and Ophthalmology, Inc.
PURPOSE: Oxidative stress and inflammation have key roles in the light damage (LD) model of retinal degeneration as well as in age-related macular degeneration (AMD). We sought to determine if lipoic acid (LA), an antioxidant and iron chelator, protects the retina against LD. METHODS: Balb/c mice were treated with LA or control saline via intraperitoneal injection, and then were placed in constant cool white light-emitting diode (LED) light (10,000 lux) for 4 hours. Retinas were evaluated at several time points after LD. Photoreceptor apoptosis was assessed using the TUNEL assay. Retinal function was analyzed via electroretinography (ERG). Retinal degeneration was assessed after LD by optical coherence tomography (OCT), TUNEL analysis, and histology. The mRNAs of several oxidative stress, inflammation, and iron-related genes were quantified by quantitative PCR (qPCR). RESULTS: The LD resulted in substantial photoreceptor-specific cell death. Dosing with LA protected photoreceptors, decreasing the numbers of TUNEL-positive photoreceptors and increasing the number of surviving photoreceptors. The retinal mRNA levels of genes indicating oxidative stress, inflammation, and iron accumulation were lower following LD in mice treated with LA than in control mice. The ERG analysis demonstrated functional protection by LA. CONCLUSIONS: Systemic LA is protective against light-induced retinal degeneration. Since this agent already has proven protective in other retinal degeneration models, and is safe and protective against diabetic neuropathy in patients, it is worthy of consideration for a human clinical trial against retinal degeneration or AMD. Copyright 2014 The Association for Research in Vision and Ophthalmology, Inc.
Authors: Xining He; Paul Hahn; Jared Iacovelli; Robert Wong; Chih King; Robert Bhisitkul; Mina Massaro-Giordano; Joshua L Dunaief Journal: Prog Retin Eye Res Date: 2007-08-11 Impact factor: 21.198
Authors: Lincoln V Johnson; William P Leitner; Alexander J Rivest; Michelle K Staples; Monte J Radeke; Don H Anderson Journal: Proc Natl Acad Sci U S A Date: 2002-08-20 Impact factor: 11.205
Authors: J Lin; A Bierhaus; P Bugert; N Dietrich; Y Feng; F Vom Hagen; P Nawroth; M Brownlee; H-P Hammes Journal: Diabetologia Date: 2006-03-07 Impact factor: 10.122
Authors: Brandon E Tullis; Renee C Ryals; Aaron S Coyner; Michael J Gale; Alex Nicholson; Cristy Ku; Dain Regis; Wrik Sinha; Shreya Datta; Yuquan Wen; Paul Yang; Mark E Pennesi Journal: Invest Ophthalmol Vis Sci Date: 2015-07 Impact factor: 4.799
Authors: Giovanni Pagano; Federico V Pallardó; Alex Lyakhovich; Luca Tiano; Marco Trifuoggi Journal: Cell Mol Life Sci Date: 2021-10-31 Impact factor: 9.261
Authors: Benjamin J Kim; Allan Hunter; Alexander J Brucker; Paul Hahn; Karen Gehrs; Apurva Patel; Albert O Edwards; Yafeng Li; Rahul N Khurana; Itzhak Nissim; Ebenezer Daniel; Juan Grunwald; Gui-Shuang Ying; Maxwell Pistilli; Maureen G Maguire; Joshua L Dunaief Journal: Ophthalmol Retina Date: 2020-04-02
Authors: Giuseppe Carota; Simone Ronsisvalle; Federica Panarello; Daniele Tibullo; Anna Nicolosi; Giovanni Li Volti Journal: J Clin Med Date: 2021-05-25 Impact factor: 4.241
Authors: Aaron S Coyner; Renee C Ryals; Cristy A Ku; Cody M Fischer; Rachel C Patel; Shreya Datta; Paul Yang; Yuquan Wen; René Hen; Mark E Pennesi Journal: PLoS One Date: 2016-07-22 Impact factor: 3.240